D-0100-2021 Class III Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
November 25, 2020
Initiation Date
November 11, 2020
Termination Date
June 24, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,088 cartons

Product Description

Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.

Reason for Recall

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Distribution Pattern

Product was distributed Nationwide in the USA.

Code Information

Lot Number: 1351104, Exp 08/2021